• Home
  • Company
  • Our Lead Product
  • Pipeline
  • News-Media
  • Contact Us
  • Home
  • Company
  • Our Lead Product
  • Pipeline
  • News-Media
  • Contact Us

News

Startseite » News
Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia 14. December 2022
Company
Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia
ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral Implant 29. October 2022
Company
ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral Implant
European Medicines Agency Grants PRIME Designation to BIT Pharma’s NicaPlant® for Treatment of Non-traumatic Subarachnoid Haemorrhage in Patients undergoing Surgery. 19. October 2022
Pipeline
European Medicines Agency Grants PRIME Designation to BIT Pharma’s NicaPlant® for Treatment of Non-traumatic Subarachnoid Haemorrhage in Patients undergoing Surgery.
BIT Pharma is Honoured to Work with a World’s Top Neurosurgery Department 10. October 2022
Team
BIT Pharma is Honoured to Work with a World’s Top Neurosurgery Department
BIT Pharma Announces the Presentation of NicaPlant® Phase 2 Results at International Conferences 31. August 2022
Pipeline
BIT Pharma Announces the Presentation of NicaPlant® Phase 2 Results at International Conferences
BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in  Aneurysmal Subarachnoid Heamorrhage patients (aSAH) undergoing aneurysm clipping. 1. July 2022
Pipeline
BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in Aneurysmal Subarachnoid Heamorrhage patients (aSAH) undergoing aneurysm clipping.
PRESS INFORMATION 14. April 2021
Company
PRESS INFORMATION
BIT PHARMA TOP15 MOST PROMISING BIOTECH STARTUPS IN EUROPE 22. May 2020
Company
BIT PHARMA TOP15 MOST PROMISING BIOTECH STARTUPS IN EUROPE
JÖRG BREITENBACH INDUCTED into  MEDICAL and BIOLOGICAL ENGINEERING ELITE 30. March 2020
Team
JÖRG BREITENBACH INDUCTED into MEDICAL and BIOLOGICAL ENGINEERING ELITE
NICAPLANT GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION 27. December 2019
Pipeline
NICAPLANT GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION
Load More
LEAD PRODUCT
NicaPlant®
BIT PHARMA
Company
Lead Product
Pipeline
Team and Management
Scientific Literature
News-Media
Contact
LEGAL
Privacy Policy
Copyright

Funded by seed financing of the BMWFW, processed by Austria Wirtschafts Service.


BMWFW

Austria Wirtschaftsservice
© 2016 BIT Pharma. All Rights Reserved.
Contact Us

Send us an email for further inquiry.

Not readable? Change text.